Inhibition of arachidonate 5-lipoxygenase triggers prostate cancer cell death through rapid activation of c-Jun N-terminal kinase

Biochemical and Biophysical Research Communications

Volumn 307, Issue 2, 2003, Pages 342-349

  Ghosh, Jagadananda ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

5(S) Hydroxyeicosatetraenoic acid; 5 Lipoxygenase; Apoptosis; C Jun N terminal kinase

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; BENZYLOXYCARBONYLASPARTYLGLUTAMYLVALYLASPARTYL FLUOROMETHYL KETONE; BENZYLOXYCARBONYLISOLEUCYLGLUTAMYLTHREONYLASPARTYL FLUOROMETHYL KETONE; CASPASE 3 INHIBITOR; CASPASE INHIBITOR; CURCUMIN; HYDROXYICOSATETRAENOIC ACID; PHOSPHOTRANSFERASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOMA CELL; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; DRUG PENETRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CARCINOMA; SIGNAL TRANSDUCTION;

EID: 0038013796     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01201-4     Document Type: Article

References (56)

1. Kondo Y., Homma Y., Aso Y., Kakizoe T. Promotional effect of two-generation exposure to a high-fat diet on prostate carcinogenesis in ACI/Seg rats. Cancer Res. 54:1994;6129-6132.
2. Meikle A.W., Smith J.A. Epidemiology of prostate cancer. Urol. Clin. North Am. 17:1990;709-718.
3. Wang Y., Corr J.G., Thaler H.T., Tao Y., Fair W.R., Heston W.D. Decreased growth of established prostate LNCaP tumors in nude mice fed a low-fat diet. J. Natl. Can. Inst. 87:1995;1456-1462.
4. Ross R.K., Henderson B.E. Do diet and androgens alter prostate cancer risk via a common etiologic pathway. J. Natl. Can. Inst. 86:1994;252-254.
5. Le M.L., Kolonel L.N., Wilkens L.R., Myers B.C., Hirohata T. Animal fat consumption and prostate cancer: a prospective study in Hawaii [see comments]. Epidemiology. 5:1994;276-282.
6. Hayes R.B., Ziegler R.G., Gridley G., Swanson C., Greenberg R.S., Swanson G.M., Schoenberg J.B., Silverman D.T., Brown L.M., Pottern L.M., Liff J., Schwartz A.G., Fraumeni J.F., Hoover R.N. Dietary factors and risks for prostate cancer among blacks and whites in the United States. Cancer Epidemiol. Biomarkers Prevention. 8:1999;25-34.
7. Brawley O.W., Thompson I.M. Chemoprevention of prostate cancer. Urology. 43:1994;594-599.
8. West D.W., Slattery M.L., Robison L.M., French T.K., Mahoney A.W. Adult dietary intake and prostate cancer risk in Utah: a case control study with special emphasis on aggressive tumors. Cancer Causes Control. 2:1991;85-94.
9. Giovannucci E.L., Rimm E.B., Colditz G.A., Stampfer M.J., Ascherio A., Chute C., Willett W.C. A prospective study of dietary fat and risk of prostate cancer. J. Natl. Can. Inst. 85:1993;1571-1579.
10. Gann P.H., Hennekens C.H., Sacks F.M., Grodstein F., Giovannucci E.L., Stampfer M.J. Prospective study of plasma fatty acids and risk of prostate cancer. J. Natl. Can. Inst. 86:1994;281-286.
11. Ghosh J., Myers C.E. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem. Biophys. Res. Commun. 235:1997;418-423.
12. Ghosh J., Myers C.E. Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells. Proc. Natl. Acad. Sci. USA. 95:1998;13182-13187.
13. Kyriakis J.M., Banerjee P., Nikolakaki E., Dai T., Rubie E.A., Ahmad M.F., Avruch J., Woodgett J.R. The stress-activated protein kinase subfamily of c-Jun kinases. Nature. 369:1994;156-160.
14. Derijard B., Hibi M., Wu I.H., Barrett T., Su B., Deng T., Karin M., Davis R.D. JNK-1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell. 76:1994;1025-1037.
15. Yu R., Jiao J.J., Duh J.L., Tan T.H., Kong A.N. Phenethyl isothiocyanate, a natural chemopreventive agent, activates c-Jun N-terminal kinase 1. Cancer Res. 56:1996;2954-2959.
16. Brunet A., Pouyssegur J. Identification of MAP kinase domains by redirecting stress signals into growth factor responses. Science. 272:1996;1652-1655.
17. Kyriakis J.M., Avruch J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:1996;24313-24316.
18. Maroney A.C., Finn J.P., Bozyczko-Coyne D., O'Kane T.M., Neff N.T., Tolkovsky A.M., Park D.S., Yan C.Y., Troy C.M., Greene L.A. CEP-1347 (KT 7515), an inhibitor of JNK activation, rescues sympathetic neurons and neuronally differentiated PC12 cells from death evoked by three distinct insults. J. Neurochem. 73:1999;1901-1912.
19. Minden A., Lin A., Smeal T., Derijard B., Cobb M., Davis R., Karin M. c-Jun N-terminal phosphorylation correlates with activation of the JNK subgroup but not the ERK subgroup of mitogen-activated protein kinases. Mol. Cell. Biol. 14:1994;6683-6688.
20. Bost F., McKay R., Dean N., Mercola D. The JUN kinase/stress-activated protein kinase pathway is required for epidermal growth factor stimulation of growth of human A549 lung carcinoma cells. J. Biol. Chem. 272:1997;33422-33429.
21. Sakata N., Patel H.R., Terada N., Arufo A., Johnson G.L., Gelfand E.W. Selective activation of c-Jun kinase mitogen-activated protein kinase by CD40 on human B cells. J. Biol. Chem. 270:1995;30823-30828.
22. Ip Y.T., Davis R.J. Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr. Opin. Cell Biol. 10:1998;205-219.
23. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. JNK is involved in signal integration during costimulation of T lymphocytes. Cell. 77:1994;727-736.
24. Behrens A., Sabapathy K., Graef I., Cleary M., Crabtree G.R., Wagner E.F. Jun N-terminal kinase 2 modulates thymocyte apoptosis and T cell activation through c-Jun and nuclear factor of activated T cell (NF-AT). Proc. Natl. Acad. Sci. USA. 98:2001;1769-1774.
25. Chen Y.R., Wang X., Templeton D., Davis R., Tan T.H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation: duration of JNK activation may determine cell death and proliferation. J. Biol. Chem. 271:1996;31929-31936.
26. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
27. Hibi M., Lin A., Smeal T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
28. Gupta S., Campbell D., Derijard B., Davis R.J. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
29. Whitmarsh A.J., Shore P., Sharrocks A.D., Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science. 269:1995;403-407.
30. Janknecht R., Hunter T. Activation of the Sap-1a transcription factor by the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase. J. Biol. Chem. 272:1997;4219-4224.
31. Chow C.W., Rincon M., Cavanagh J., Dickens M., Davis R.J. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway. Science. 278:1997;1638-1641.
32. Leppa S., Bohmann D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene. 18:1999;6158-6162.
33. Bazenet C.E., Mota M.A., Rubin L.L. The small GTP-binding protein Cdc42 is required for nerve growth factor withdrawal-induced neuronal death. Proc. Natl. Acad. Sci. USA. 95:1998;3984-3989.
34. Cheng H.L., Steinway M.L., Xin X., Feldman E.L. Insulin-like growth factor-1 and Bcl-xl inhibit c-Jun N-terminal kinase activation and rescue Schwann cells from apoptosis. J. Neurochem. 76:2001;935-943.
35. Johnson E.M., Deckworth T.L., Deshmukh M. Neuronal death in developmental models: possible implications in neuropathology. Brain Pathol. 6:1996;397-409.
36. Le-Niculescu H., Bonfoco E., Kasuya Y., Claret F.X., Green D.R., Karin M. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death. Mol. Cell. Biol. 19:1999;751-763.
37. Watson A., Eilers A., Lallemand D., Kyriakis J., Rubin L.L., Ham J. Phosphorylation of c-Jun is necessary for apoptosis induced by survival signal withdrawal in cerebellar granule neurons. J. Neurosci. 18:1998;751-762.
38. 2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma. Cell Growth Diff. 12:2001;137-145.
39. Aloyz R.S., Bamji S.X., Pozniak C.D., Toma J.G., Atwal J., Kaplan D.R., Miller F.D. p53 is essential for developmental neuron death as regulated by the TrkA and p75 neurotrophin receptors. J. Cell. Biol. 143:1998;1691-1703.
40. Smeal T., Binetruy B., Mercola D.A., Birrer M., Karin M. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serine 63 and 73. Nature. 354:1991;494-496.
41. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
42. Longthorne V.L., Williams G.T. Caspase activity is required for commitment to Fas-mediated apoptosis. EMBO J. 16:1997;3805-3812.
43. Chen Y.R., Tan T.H. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene. 17:1998;173-178.
44. Chen Y.R., Zhou G., Tan T.H. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl) retinamide. Mol. Pharmacol. 56:1999;1271-1279.
45. Du J., Suzuki H., Nagase F., Akhand A.A., Yokoyama T., Miyata T., Kurokawa K., Nakashima I. Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. J. Cell. Biochem. 77:2000;333-344.
46. Bennett B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W., Leisten J.C., Motiwala A., Pierce S., Satoh Y., Bhagwat S.S., Manning A.M., Anderson D.W. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA. 98:2001;13681-13686.
47. Ghosh J., Myers C.E. Molecular mechanisms of prostate cancer cell death triggered by inhibition of arachidonate 5-lipoxygenase: involvement of Fas/FasL-mediated signals. Adv. Exp. Med. Biol. 507:2002;415-420.
48. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J.C., Arkinstall S. Bcl-2 undergoes phosphorylation by the c-Jun N-terminal kinase/stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac. J. Biol. Chem. 272:1997;25238-25242.
49. L in response to DNA damage. J. Biol. Chem. 275:2000;322-327.
50. Milne D.M., Campbell L.E., Campbell D.G., Meek D.W. p53 is phosphorylated in vitro and in vivo by an ultraviolet radiation-induced protein kinase characteristic of the c-Jun kinase JNK1. J. Biol. Chem. 270:1995;5511-5518.
51. Bushmann T., Potapova O., Bar-Shira A., Ivanov V.N., Fuchs S.Y., Henderson S., Fried V.A., Minamoto T., Alarcon-Vargas D., Pincus M.R., Gaarde W.A., Holbrook N., Shiloh Y., Ronai Z. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress. Mol. Cell. Biol. 21:1997;2743-2754.
52. Inoshita S., Takeda K., Hatai T., Terada Y., Sano M., Hata J., Umezawa A., Ichijo H. Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress. J. Biol. Chem. 277:2002;43730-43734.
53. Engedal N., Korkmaz C.G., Saatcioglu F. c-Jun N-terminal kinase is required for phorbol-ester- and thapsigargin-induced apoptosis in the androgen-responsive prostate cancer cell line LNCaP. Oncogene. 21:2002;1017-1027.
54. Cahill M.A., Peter M.E., Kischkel F.C., Chinnaiyan A.M., Dixit V.M., Krammer P.H., Nordheim A. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases. Oncogene. 13:1996;2087-2096.
55. Faris M., Kokot N., Latinis K., Kasibhatla S., Green D.R., Koretzky G.A., Nel A. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression. J. Immunol. 160:1998;134-144.
56. Kolbus A., Herr I., Schreiber M., Debatin K.M., Wagner E.F., Angel P. c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents. Mol. Cell. Biol. 20:2000;575-582.